Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 2
2009 1
2011 1
2012 3
2015 1
2016 4
2017 1
2018 5
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
[The intestinal microbiota composition in patients with multiple sclerosis receiving different disease-modifying therapies DMT].
Abdurasulova IN, Tarasova EA, Nikiforova IG, Il'ves AG, Ivashkova EV, Matsulevich AV, Tatarinov AE, Shangina LV, Ermolenko EI, Klimenko VM, Stolyarov ID, Suvorov AN. Abdurasulova IN, et al. Among authors: stolyarov id. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):62-69. doi: 10.17116/jnevro201811808262. Zh Nevrol Psikhiatr Im S S Korsakova. 2018. PMID: 30160670 Russian.
[Clinical recommendations on the use of teriflunomide].
Alifirova VM, Bakhtiyarova KZ, Belova AN, Bisaga GN, Boiko AN, Boiko OV, Vlasov YV, Volkova LI, Goncharova ZA, Davydovskaya MV, Zakharova MN, Kotov SV, Lashch NY, Malkova NA, Petrov AM, Popova EV, Sivertseva SA, Sokolova IA, Spirin NN, Stolyarov ID, Streknev AG, Totolyan NA, Khachanova NV, Sherman MI, Shmidt TE, Khabirov FA, Yampol'skaya-Gosteva IA. Alifirova VM, et al. Among authors: stolyarov id. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(10 Pt 2):98-104. doi: 10.17116/jnevro201611610298-104. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 28139617 Russian. No abstract available.
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].
Evdoshenko EP, Neofidov NA, Bakhtiyarova KZ, Davydovskaya MV, Kairbekova EI, Kolontareva YM, Malkova NA, Odinak MM, Popova EV, Sazonov DV, Stolyarov ID, Smagina IV, Fedyanin AS, Habirov FA, Khaibullin TI, Khachanova NV, Shchukin IA, Boyko AN. Evdoshenko EP, et al. Among authors: stolyarov id. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):110-119. doi: 10.17116/jnevro201911910110. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31934996 Clinical Trial. Russian.
20 results